Literature DB >> 19295526

Emerging methods for the production of homogeneous human glycoproteins.

Jamie R Rich1, Stephen G Withers.   

Abstract

Most circulating human proteins exist as heterogeneously glycosylated variants (glycoforms) of an otherwise homogeneous polypeptide. Though glycan heterogeneity is most likely important to glycoprotein function, the preparation of homogeneous glycoforms is important both for the study of the consequences of glycosylation and for therapeutic purposes. This review details selected approaches to the production of homogeneous human N- and O-linked glycoproteins with human-type glycans. Particular emphasis is placed on recent developments in the engineering of glycosylation pathways within yeast and bacteria for in vivo production, and on the in vitro remodeling of glycoproteins by enzymatic means. The future of this field is very exciting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295526     DOI: 10.1038/nchembio.148

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  105 in total

Review 1.  Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.

Authors:  Robert G Spiro
Journal:  Glycobiology       Date:  2002-04       Impact factor: 4.313

Review 2.  Homogeneous glycopeptides and glycoproteins for biological investigation.

Authors:  Michael J Grogan; Matthew R Pratt; Lisa A Marcaurelle; Carolyn R Bertozzi
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 4.  Strategies for the preparation of homogenous glycoproteins.

Authors:  Ashraf Brik; Simon Ficht; Chi-Huey Wong
Journal:  Curr Opin Chem Biol       Date:  2006-10-13       Impact factor: 8.822

Review 5.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 6.  Synthetic glycobiology: Exploits in the Golgi compartment.

Authors:  Jennifer L Czlapinski; Carolyn R Bertozzi
Journal:  Curr Opin Chem Biol       Date:  2006-10-23       Impact factor: 8.822

7.  GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli.

Authors:  Shawn DeFrees; Zhi-Guang Wang; Ruye Xing; Arthur E Scott; Jin Wang; David Zopf; Dominique L Gouty; Eric R Sjoberg; Krishnasamy Panneerselvam; Els C M Brinkman-Van der Linden; Robert J Bayer; Mads A Tarp; Henrik Clausen
Journal:  Glycobiology       Date:  2006-05-22       Impact factor: 4.313

Review 8.  Glycopeptide and glycoprotein synthesis involving unprotected carbohydrate building blocks.

Authors:  Zhongwu Guo; Ning Shao
Journal:  Med Res Rev       Date:  2005-11       Impact factor: 12.944

9.  Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.

Authors:  Lai-Xi Wang; Jiahong Ni; Suddham Singh; Hengguang Li
Journal:  Chem Biol       Date:  2004-01

10.  Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains in Saccharomyces cerevisiae.

Authors:  Y Chiba; M Suzuki; S Yoshida; A Yoshida; H Ikenaga; M Takeuchi; Y Jigami; E Ichishima
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  45 in total

Review 1.  Emerging technologies for making glycan-defined glycoproteins.

Authors:  Lai-Xi Wang; Joseph V Lomino
Journal:  ACS Chem Biol       Date:  2011-12-14       Impact factor: 5.100

Review 2.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

3.  Syntheses of mucin-type O-glycopeptides and oligosaccharides using transglycosylation and reverse-hydrolysis activities of Bifidobacterium endo-alpha-N-acetylgalactosaminidase.

Authors:  Hisashi Ashida; Hayato Ozawa; Kiyotaka Fujita; Shun'ichi Suzuki; Kenji Yamamoto
Journal:  Glycoconj J       Date:  2009-06-27       Impact factor: 2.916

Review 4.  Fc glycan-modulated immunoglobulin G effector functions.

Authors:  Isaak Quast; Jan D Lünemann
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

5.  Unusual transglycosylation activity of Flavobacterium meningosepticum endoglycosidases enables convergent chemoenzymatic synthesis of core fucosylated complex N-glycopeptides.

Authors:  Wei Huang; Jie Li; Lai-Xi Wang
Journal:  Chembiochem       Date:  2011-03-04       Impact factor: 3.164

6.  Production of homogeneous glycoprotein with multisite modifications by an engineered N-glycosyltransferase mutant.

Authors:  Qitao Song; Zhigang Wu; Yueyuan Fan; Woran Song; Peiru Zhang; Li Wang; Faxing Wang; Yangyang Xu; Peng G Wang; Jiansong Cheng
Journal:  J Biol Chem       Date:  2017-04-05       Impact factor: 5.157

Review 7.  Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions.

Authors:  Lai-Xi Wang; Mohammed N Amin
Journal:  Chem Biol       Date:  2014-01-16

8.  Toward Homogeneous Erythropoietin: Application of Metal Free Dethiylation in the Chemical Synthesis of the Ala79-Arg166 Glycopeptide Domain.

Authors:  Suwei Dong; Shiying Shang; Zhongping Tan; Samuel J Danishefsky
Journal:  Isr J Chem       Date:  2011-11       Impact factor: 3.333

Review 9.  Chemoenzymatic Methods for the Synthesis of Glycoproteins.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Chem Rev       Date:  2018-08-24       Impact factor: 60.622

10.  A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation.

Authors:  Flavio Schwarz; Wei Huang; Cishan Li; Benjamin L Schulz; Christian Lizak; Alessandro Palumbo; Shin Numao; Dario Neri; Markus Aebi; Lai-Xi Wang
Journal:  Nat Chem Biol       Date:  2010-02-28       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.